BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ye S, Long YM, Rong J, Xie WR. Nuclear factor kappa B: A marker of chemotherapy for human stage IV gastric carcinoma. World J Gastroenterol 2008; 14(30): 4739-4744 [PMID: 18720533 DOI: 10.3748/wjg.14.4739]
URL: https://www.wjgnet.com/1007-9327/full/v14/i30/4739.htm
Number Citing Articles
1
Amit K. Garg, Anuja Jhingran, Ann H. Klopp, Bharat B. Aggarwal, Ajai B. Kunnumakkara, Russell R. Broadus, Patricia J. Eifel, Thomas A. Buchholz. Expression of Nuclear Transcription Factor Kappa B in Locally Advanced Human Cervical Cancer Treated With Definitive ChemoradiationInternational Journal of Radiation Oncology*Biology*Physics 2010; 78(5): 1331 doi: 10.1016/j.ijrobp.2009.09.044
2
Jiyeon Yoon, Sung Jin Cho, Young San Ko, Jinju Park, Dong Hoon Shin, In Chan Hwang, Sang Yeun Han, Seon Young Nam, Min A Kim, Mee Soo Chang, Hye Seung Lee, Woo Ho Kim, Byung Lan Lee. A synergistic interaction between transcription factors nuclear factor-κB and signal transducers and activators of transcription 3 promotes gastric cancer cell migration and invasionBMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-29
3
Yujie Zhang, Zhaowei Meng, Mingfang Zhang, Jian Tan, Weijun Tian, Xianghui He, Qiang Fu, Ke Xu, Qing He, Mei Zhu, Xue Li, Guizhi Zhang, Yajing He, Qiang Jia, Jianping Zhang, Sheng Wang, Xinghua Song. Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasisLife Sciences 2014; 118(1): 39 doi: 10.1016/j.lfs.2014.09.025
4
Kanjoormana A. Manu, Muthu K. Shanmugam, Lalitha Ramachandran, Feng Li, Kodappully Sivaraman Siveen, Arunachalam Chinnathambi, M.E. Zayed, Sulaiman Ali Alharbi, Frank Arfuso, Alan Prem Kumar, Kwang Seok Ahn, Gautam Sethi. Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancerCancer Letters 2015; 363(1): 28 doi: 10.1016/j.canlet.2015.03.033
5
Marta Smolińska, Dariusz Grzanka, Paulina Antosik, Anna Kasperska, Izabela Neska-Długosz, Jakub Jóźwicki, Anna Klimaszewska-Wiśniewska. HER2, NF-κB, and SATB1 Expression Patterns in Gastric Cancer and Their Correlation with Clinical and Pathological ParametersDisease Markers 2019; 2019: 1 doi: 10.1155/2019/6315936
6
José Esparza‑lópez, Ossian Longoria, Eliseo De La Cruz‑escobar, Julio Garibay‑díaz, Eucario León‑rodríguez, María Ibarra‑sánchez. Paclitaxel resistance is mediated by NF‑κB on mesenchymal primary breast cancer cellsOncology Letters 2021; 23(2) doi: 10.3892/ol.2021.13168
7
Chen Yu, Ai-Jun Ji, Jian-Wei Lu, Shi-Jia Liu, Yu Sun. The Antigastric Cancer Activity of San Leng Powder Extract Induces Apoptosis in Balb/C Bearing-SGC-7901 MiceEvidence-Based Complementary and Alternative Medicine 2017; 2017: 1 doi: 10.1155/2017/1052125
8
Koichiro Haruki, Hiroaki Shiba, Yuki Fujiwara, Kenei Furukawa, Ryota Iwase, Tadashi Uwagawa, Takeyuki Misawa, Toya Ohashi, Katsuhiko Yanaga. Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in MiceDigestive Diseases and Sciences 2013; 58(1): 123 doi: 10.1007/s10620-012-2311-4
9
Atena Soleimani, Farzad Rahmani, Gordon A. Ferns, Mikhail Ryzhikov, Amir Avan, Seyed Mahdi Hassanian. Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancerGene 2020; 726: 144132 doi: 10.1016/j.gene.2019.144132
10
YANPEI SUN, YAN ZHAO, LIYING HOU, XUGUANG ZHANG, ZHIHONG ZHANG, KUN WU. RRR-α-tocopheryl succinate induces apoptosis in human gastric cancer cells via the NF-κB signaling pathwayOncology Reports 2014; 32(3): 1243 doi: 10.3892/or.2014.3282
11
Xiu-Li Guo, Ya-Jie Wang, Pei-Lin Cui, Yan-Bin Wang, Pi-Xia Liang, Ya-Nan Zhang, You-Qing Xu. Effect of BRMS1 expression on proliferation, migration and adhesion of mouse forestomach carcinomaAsian Pacific Journal of Tropical Medicine 2015; 8(9): 724 doi: 10.1016/j.apjtm.2015.07.020
12
Chen Yao, Min Zhang, JinFeng Zou, HongDong Li, Dong Wang, Jing Zhu, Zheng Guo. Functional modules with disease discrimination abilities for various cancersScience China Life Sciences 2011; 54(2): 189 doi: 10.1007/s11427-010-4129-7
13
Manuela Labbozzetta, Monica Notarbartolo, Paola Poma. Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of ViewInternational Journal of Molecular Sciences 2020; 21(9): 3070 doi: 10.3390/ijms21093070
14
Olga Sokolova, Michael Naumann. NF‐κB Signaling in Gastric CancerToxins 2017; 9(4): 119 doi: 10.3390/toxins9040119
15
Sahil Gambhir, Dinesh Vyas, Michael Hollis, Apporva Aekka, Arpita Vyas. Nuclear factor kappa B role in inflammation associated gastrointestinal malignanciesWorld Journal of Gastroenterology 2015; 21(11): 3174-3183 doi: 10.3748/wjg.v21.i11.3174
16
Ying Chen, Renquan Lu, Hui Zheng, Ran Xiao, Jingjing Feng, Hongling Wang, Xiang Gao, Lin Guo. The NFKB1 polymorphism (rs4648068) is associated with the cell proliferation and motility in gastric cancerBMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0243-0
17
Y. Nariai, K. Mishima, Y. Yoshimura, J. Sekine. FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosisInternational Journal of Oral and Maxillofacial Surgery 2011; 40(4): 419 doi: 10.1016/j.ijom.2010.10.020
18
Kanjoormana A. Manu, Muthu K. Shanmugam, Feng Li, Luxi Chen, Kodappully Sivaraman Siveen, Kwang Seok Ahn, Alan Prem Kumar, Gautam Sethi. Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene productsJournal of Molecular Medicine 2014; 92(3): 267 doi: 10.1007/s00109-013-1095-0
19
Min Sun Kim, Dae-Yeol Lee. Insulin-like growth factor binding protein-3 enhances etoposide-induced cell growth inhibition by suppressing the NF-κB activity in gastric cancer cellsMolecular and Cellular Biochemistry 2015; 403(1-2): 107 doi: 10.1007/s11010-015-2341-2
20
Supattra Chaithongyot, Phatcharida Jantaree, Olga Sokolova, Michael Naumann. NF-κB in Gastric Cancer Development and TherapyBiomedicines 2021; 9(8): 870 doi: 10.3390/biomedicines9080870